Protease activated receptor 2 antagonist in inflammatory disease (2010–2012)

Grant type:
NHMRC Development Grant
Researchers:
  • NHMRC Leadership Fellow and Group L
    Institute for Molecular Bioscience
    NHMRC Leadership Fellow and Group L
    Institute for Molecular Bioscience
    Affiliate of ARC COE for Innovation
    ARC Centre of Excellence for Innovations in Peptide and Protein Science
    Institute for Molecular Bioscience
    of Institute for Molecular Bioscien
    Institute for Molecular Bioscience
  • ATH - Associate Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
Funded by:
National Health and Medical Research Council